Continue reading here:
Matinas BioPharma Awarded up to $3.75 Million from the Cystic Fibrosis Foundation to Support Development of Oral Amikacin (MAT2501) for the Treatment...
Read the original here:
BioCryst to Present at Upcoming Virtual Investment Conferences
Read more here:
BioRestorative Therapies Emerges from Chapter 11 Reorganization
Go here to see the original:
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Here is the original post:
Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders
Read the original post:
LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering